VEGFA and kidney neoplasm: Besides optimising ADC production processes and seeking specific targets for renal tumors, considering the high vascularisation characteristic of renal tumors, the combined use of ADCs with drugs targeting VEGF, such as TKIs, might produce good results (38, 46).